WO2004005269A1 - Method for producing substituted thiazol-2-yl methyl esters - Google Patents
Method for producing substituted thiazol-2-yl methyl esters Download PDFInfo
- Publication number
- WO2004005269A1 WO2004005269A1 PCT/EP2003/007414 EP0307414W WO2004005269A1 WO 2004005269 A1 WO2004005269 A1 WO 2004005269A1 EP 0307414 W EP0307414 W EP 0307414W WO 2004005269 A1 WO2004005269 A1 WO 2004005269A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- alkyl
- hydrogen atom
- heteroalkyl
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- SXFXBNIMBIRULN-UHFFFAOYSA-N CC(C)C(CC(c1nc(C(OC)=O)c[s]1)O)N(C)C(C)=O Chemical compound CC(C)C(CC(c1nc(C(OC)=O)c[s]1)O)N(C)C(C)=O SXFXBNIMBIRULN-UHFFFAOYSA-N 0.000 description 1
- JJBOGSGPEAWOBL-UHFFFAOYSA-N CC(C)C(CC(c1nc(C(OC)=O)c[s]1)O)N(C)C(c1ccccc1)=O Chemical compound CC(C)C(CC(c1nc(C(OC)=O)c[s]1)O)N(C)C(c1ccccc1)=O JJBOGSGPEAWOBL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Definitions
- the present invention relates to a new process for the preparation of substituted thiazol-2-ylmethyl esters via a multicomponent reaction. These compounds are of particular interest in the synthesis of tubulysins and tubulysin derivatives.
- Thiazol-2-methyl esters are found in numerous biologically active natural products as well as synthetic derivatives such as. B. Lyngbyabellin A and B, tubulysins, thiostreptones, myxothiazoles, archazolid A, tallysomycin, bleomycin, dysidenin, dolabellin and synthetic epothilone derivatives (Yokokawa et al. Tetrahedron et al. 2001, 42, 4171-4174; Konishi et al Antibiot 1977, 30, 789-805; Sone et al. J. Org. Chem. 1995, 60, 4774-4781; Kazlauskas et al. Tetrahedron Lett. 1977, 36, 3183-3186) and therefore is simpler and more efficient Access to this class of substances is particularly important in the synthesis of active substances.
- the object of the present invention was in particular to provide a new one-pot process for the preparation of these compounds, which takes place in a multi-component reaction. Since multicomponent reactions are very variable, they are particularly suitable for the synthesis of substance libraries to find lead structures in the pharmaceutical industry (A. Dömling, I. Ugi, Angew. Chem. 2000, 112, 3300-3344). Another object of the present invention was to use this method to provide an efficient synthesis of the tubulysin class of compounds.
- the Tubulysins were first developed by the Höfle and
- Tubulysins (I) are tetrapeptides that contain three unusual amino acids, making their synthesis a challenge for organic synthetic chemistry.
- R 2 H,
- R 4 is a hydrogen atom, an alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, heterocycloalkyl, aralkyl or a heteroaralkyl radical or a group of the formula COO -L-Pol is where L is a linker and Pol is a polymeric support;
- R 5 is a hydrogen atom, an alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, heterocycloalkyl, aralkyl or a heteroaralkyl radical;
- R 6 is a hydrogen atom, an alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, heterocycloalkyl, aralkyl or a heteroaralkyl radical;
- R 7 is a hydrogen atom, an alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, heterocycloalkyl, aralkyl or a heteroaralkyl radical and R 8 is a hydrogen atom, an alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, heterocycloalkyl, aralkyl or a heteroaralkyl radical.
- alkyl or alk refers to a saturated, straight-chain or branched hydrocarbon group which has 1 to 20 carbon atoms, preferably 1 to 12 carbon atoms, particularly preferably 1 to 6 carbon atoms, e.g. the methyl, ethyl, propyl, isopropyl, isobutyl, tert-butyl, n-hexyl, 2, 2-dimethylbutyl or n-octyl group.
- alkenyl and alkynyl refer to at least partially unsaturated, straight-chain or branched hydrocarbon groups, the 2 to 20
- Alkenyl groups preferably have one or two (particularly preferably one) double bonds or
- alkyl, alkenyl and alkynyl refer to groups in which one or more hydrogen atoms have been replaced by a halogen atom (preferably F or CD, such as the 2, 2, 2-trichloroethyl or the trifluoromethyl group).
- a halogen atom preferably F or CD, such as the 2, 2, 2-trichloroethyl or the trifluoromethyl group.
- heteroalkyl groups are groups of the formulas R ⁇ OY * -, R a _ s _ ⁇ a _ # R a -N (R b ) -Y a -, R a -CO-Y a -, R-0-CO- Y a - R a -CO-0-Y a -, R a -CO-N (R b ) -Y a -, R a -N (R b ) -CO-Y a -
- R a -0-CO-N (R b ) -Y a -, R a -N (R b ) -CO-0-Y a -, R a -N (R b ) -CO-N (R c ) -Y a - R a -0-CO-0-Y a -, R a -N (R b ) -C ( NR d ) -N (R C ) -Y a -, R a -CS-Y a - R a -0-CS-Y a -, R a -CS-0-Y a -, R a -CS-N (R b ) -Y a -, R a -N (R b ) -CS-Y a - R a -0-CS-N (R b ) -Y a -, R a -N (R b ) -CS-Y a
- Is -C 6 alkylene, a C 2 -C 6 alkenylene or a C 2 -C 6 alkynylene group, each heteroalkyl group containing at least one carbon atom and one or more hydrogen atoms can be replaced by fluorine or chlorine atoms.
- heteroalkyl groups are methoxy, trifluoromethoxy, ethoxy, n-propyloxy, iso-propyloxy, tert-butyloxy, methoxymethyl, ethoxymethyl, methoxyethyl, methylamino, ethylamino, diethylamino, diethylamino, iso-propylethylamino, methylaminomethyl, ethylaminomethyl, diisopropylaminoethyl, enol ether, dimethylaminoethyl, dimethylaminoethyl, dimethylaminoethyl , Propionyl, butyryloxy, acetyloxy, methoxycarbonyl, ethoxycarbonyl, N-ethyl-N-methylcarbamoyl or N-methylcarbamoyl.
- heteroalkyl groups are nitrile, isonitrile,
- cycloalkyl refers to a saturated or partially unsaturated (e.g. cycloalkenyl) cyclic group which has one or more rings (preferably 1 or 2) which have a total of 3 to 14 ring carbon atoms, preferably 3 to 10 (especially 3 , 4, 5, 6 or 7) contain ring carbon atoms.
- B. cyclic ketones such.
- cycloalkyl groups are the cyclopropyl, cyclobutyl, cyclopentyl, spiro [4,5] decanyl, norborny, cyclohexyl, cyclopentenyl, cyclohexadienyl, decalinyl, cubanyl, bicyclo [4.3.0] nonyl -, tetralin, cyclopentylcyclohexyl, fluorocyclohexyl or the cyclohex-2-enyl group.
- Examples are the piperidyl, morpholinyl, urotropinyl, pyrrolidinyl, tetrahydrothiophenyl, tetrahydropyranyl, tetrahydrofuryl, oxacyclopropyl, azacyclopropyl or 2-pyrazolinyl group as well as lactams, lactones, cyclic imides and cyclic anhydrides.
- heteroalkylcycloalkyl refers to alkylcycloalkyl groups, as defined above, in which one or more (preferably 1, 2 or 3) carbon atoms are represented by an oxygen, nitrogen, silicon, selenium, phosphorus or sulfur atom (preferably oxygen, sulfur or Nitrogen) are replaced.
- Examples of such groups are alkyl heterocycloalkyl, alkyl heterocycloalkenyl, alkenyl heterocycloalkyl, alkynyl heterocycloalkyl, heteroalkylcycloalkyl, heteroalkyl heterocycloalkyl and heteroalkyl heterocylcloalkenyl, the cyclic groups being saturated or mono-, di- or trisaturated.
- aryl or Ar refers to an aromatic group which has one or more rings which contain a total of 6 to 14 ring carbon atoms, preferably 6 to 10 (in particular 6) ring carbon atoms.
- aryl (or Ar) also refers to groups in which one or more hydrogen atoms have been replaced by fluorine, chlorine, bromine or iodine atoms or OH, SH, NH 2 or NO 2 groups. Examples are the phenyl, naphthyl, biphenyl, 2-fluorophenyl, anilinyl, 3-nitrophenyl or 4-hydroxyphenyl group.
- heteroaryl refers to an aromatic group which has one or more rings which contain a total of 5 to 14 ring atoms, preferably 5 to 10 (in particular 5 or 6) ring atoms and one or more (preferably 1, 2, 3 or 4 ) Contain oxygen, nitrogen, phosphorus or sulfur ring atoms (preferably O, S or N).
- heteroaryl also refers to groups in which one or more hydrogen atoms have been replaced by fluorine, chlorine, bromine or iodine atoms or OH, SH, NH 2 or NO 2 groups.
- examples are 4-pyridyl, 2-imidazolyl, 3-phenylpyrrolyl, thiazolyl, oxazolyl, triazolyl, tetrazolyl, isoxazolyl, indazolyl, indolyl, benzimidazolyl, pyridazinyl, quinolinyl, purinyl, carbazolyl , Acridinyl, pyrimidyl, 2, 3 "bifuryl, 3-pyrazolyl and isoquinolinyl groups.
- aralkyl refers to groups which, according to the above definitions, contain both aryl and also alkyl, alkenyl, alkynyl and / or cycloalkyl groups, such as, for. B. arylalkyl, arylalkenyl, arylalkynyl, arylcycloalkyl, arylcycloalkenyl, alkylarylcycloalkyl and alkyl arylcycloalkenyl groups.
- aralkyls are toluene, xylene, mesitylene, styrene, benzyl chloride, o-fluorotoluene, 1H-indene, tetralin, dihydronaphthalenes, indanone, phenylcyclopentyl, cumene, cyclo-hexylphenyl, fluorene and indane.
- An aralkyl group preferably contains one or two aromatic ring systems (1 or 2 rings) with a total of 6 to 10 ring carbon atoms and one or two alkyl, alkenyl and / or alkynyl groups with 1 or 2 to 6 carbon atoms and / or a cycloalkyl group with 5 or 6 ring carbon atoms.
- heteroaralkyl refers to an aralkyl group as defined above in which one or more (preferably 1, 2, 3 or 4) carbon atoms are represented by an oxygen, nitrogen, silicon, selenium, phosphorus, boron or sulfur atom (preferably oxygen , Sulfur or nitrogen) are replaced, ie on groups which, according to the above definitions, are both aryl or heteroaryl and also alkyl, alkenyl, alkynyl and / or heteroalkyl and / or cycloalkyl and / or heterocycloalkyl groups contain.
- one Heteroaralkyl group one or two aromatic ring systems (1 or 2 rings) with a total of 5 or 6 to 10 ring carbon atoms and one or two alkyl, alkenyl and / or alkynyl groups with 1 or 2 to 6 carbon atoms and / or a cycloalkyl group with 5 or 6 ring carbon atoms, 1, 2, 3 or 4 of these carbon atoms being replaced by oxygen, sulfur or nitrogen atoms.
- Examples are aryl heteroalkyl, aryl heterocycloalkyl, aryl heterocycloalkenyl, aryl alkyl heterocycloalkyl, aryl alkenyl heterocycloalkyl, arylalkynyl heterocyclo alkyl, aryl alkyl heterocycloalkenyl, heteroaryl alkyl, hetero aryl hetero aryl hetero aryl , Heteroarylhetero- cycloalkyl-, Heteroarylheterocycloalkenyl-, Heteroarylal- kylcycloalkyl-, Heteroarylalkylheterocycloalkenyl-, arylheteroalkylcycloalkyl- hetero-, Heteroarylheteroalkylcycloalke- nyl- and Heteroarylheteroalkylheterocycloalkyl groups, WO at the cyclic groups being saturated or mono-, di-
- This expression also relates to groups which exclusively or additionally with unsubstituted -CC 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, -C-C 6 heteroalkyl, C 3 -C ⁇ 0 cycloalkyl -, C 2 -C 9 heterocycloalkyl, C 6 -C ⁇ 0 aryl, -C-C 9 heteroaryl, C 7 -C ⁇ 2 aralkyl or C 2 -Cn heteroaralkyl groups are substituted.
- Compounds of formula (I) can contain one or more centers of chirality due to their substitution.
- the present invention therefore encompasses all pure enantiomers and all pure diastereomers, as well as their mixtures in any mixing ratio.
- the present invention also includes all cis / trans isomers of the compounds of the general formula (I) and mixtures thereof.
- the present invention further encompasses all tautomeric forms of the compounds of the formula (I).
- insoluble polymeric supports are polymers based on polystyrene (crosslinked with divinylbenzene) such as.
- Merrifield resin bromo (4- methoxyphenyDmethyl Polystyrrol, 4- (bromomethyl) phenoxy ethyl Polystyrrol, the 2-Clorotrityl resin tentacle polymers such as Tentagel ®, silica gel, controlled pore glass (CPG), cellulose, copolymers and gold.
- Polymeric carriers, as well as polymeric carriers modified by linkers are available from a number of companies such as Calbiochem-Novabiochem AG, Laufelfingen, Switzerland, Bachern AG, Bubendorf, Switzerland, Rapp Polymer GmbH, Tübingen, Germany, Advanced ChemTech . Louisville, KY, USA and Shearwater Corporation, Huntsville, Alabama, USA are commercially available.
- the compounds according to the invention can be prepared by reacting compounds of the formulas (III), (IV) and (V)
- X is a leaving group such.
- B. F, Cl, Br, I, NR 9 b ⁇ R-, 10 OR 11 or SO n R 12 , wherein R 9 , R 10 , R 11 and R 12 are independently a hydrogen atom, an alkyl, heteroalkyl, aryl - Aralkyl, cycloalkyl, cycloaralkyl, heterocycloalkyl, heteroaralkyl, or a heteroaryl radical and n 0, 1, 2 or 3.
- reaction conditions e.g. addition of ammonia in methanol
- compounds of the formula (Ha) can be prepared directly:
- R 4 is particularly preferably a group of the formula COOMe, COOEt or COO' ⁇ u.
- R 5 is a hydrogen atom.
- R 6 is furthermore preferably a hydrogen atom.
- R 7 is a C ⁇ -C 6 alkyl, C 2 -C 6 - alkenyl, C 2 -C 6 alkynyl, C ⁇ -C5 heteroalkyl, C 6 - or C ⁇ 0 - aryl , C 5 -C 9 heteroaryl-, C 3 -C ⁇ 0 cycloalkyl-, C 4 -C n - alkylcycloalkyl-, C 3 -C ⁇ 0 heteroalkylcycloalkyl-, C 2 -C 9 - heterocycloalkyl-, C 7 -C 12 aralkyl or a C 5 -C 2 heteroaralkylres,
- aprotic solvent such as. B. tetrahydrofuran (THF), dioxane, diethyl ether, acetonitrile or methylene chloride, with ethers such as. B. THF are particularly preferred.
- the compounds (III), (IV) and (V) are preferably used in equimolar amounts.
- reaction temperatures are in the range from -100 ° C. to 100 ° C., reaction temperatures from -80 ° C. to 60 ° C. being particularly preferred (temperatures from -25 ° C. to 25 ° C. are particularly preferred).
- the reaction is optionally carried out in a microwave reactor.
- a Lewis acid such as. B. boron trifluoride etherate, trimethyl aluminum, lithium chloride, aluminum trichloride, zinc chloride (ZnCl 3 ), ytterbium triflate, magnesium triflate, magnesium bromide, zirconium chloride (ZrCl 4 ), titanium (IV) chloride, zinc triflate (Zn (OTf) 2 ), scandium triflate (Sc (triflate) ) 3 ), hafnium triflate (Hf (OTf) 4 ) or tin tetrachloride may be preferred.
- a Lewis acid such as. B. boron trifluoride etherate, trimethyl aluminum, lithium chloride, aluminum trichloride, zinc chloride (ZnCl 3 ), ytterbium triflate, magnesium triflate, magnesium bromide, zirconium chloride (ZrCl 4 ), titanium (IV) chloride, zinc triflate (Zn (OTf) 2 ),
- compound (III) is first dissolved in the solvent with the Lewis acid and then (preferably after 5 to 30 minutes) compounds (IV) and (V) are added.
- a key compound in the synthesis of some of the tubulysin derivatives described above is an amino acid derivative of the general formula (VI):
- This compound can be synthesized in a simple manner using the process described here by reacting compounds of the formulas (IV), (VII) and (VIII)
- PG is an amino protecting group and R 14 is a hydrogen atom, an alkyl or a heteroalkyl radical. This method is also encompassed by the present invention.
- PG is preferably a Boc group
- R is a hydrogen atom
- R 13 is a methyl, an ethyl or a tert-butyl group.
- an isoleucine derivative of the formula (IX) is used as the thiocarboxylic acid (general formula IV),
- tubulysins of the formula (I) can be carried out using the following steps starting from compound (XI): Coupling with N-pipecolic acid to compound (XII)
- the reaction is hydrolyzed with 6 ml of water and mixed with 6 ml of ethyl acetate.
- the aqueous phase is separated off and the organic phase is washed 3 times with 3 ml of saturated sodium hydrogen carbonate solution, 3 times with 3 ml of 5% citric acid and 2 times with 3 ml of saturated sodium chloride solution.
- the ethyl acetate phase is dried over sodium sulfate and evaporated.
- the raw product is purified by means of chromatotrography.
- Example 15 The compound from Example 15 (0.1 mmol) is dissolved in 2 ml dichloromethane (DCM) and 0.1 ml trifluoroacetic acid (TFA) and stirred for 1 h at room temperature. The DCM / TFA mixture is then removed in vacuo and the residue is purified by HPLC.
- DCM dichloromethane
- TFA trifluoroacetic acid
- Example 16 The compound from Example 16 (0.1 mmol) is dissolved in 2 ml of dichloromethane (DCM) and 0.1 ml of trifluoroacetic acid (TFA) and stirred at room temperature for 1 h. Subsequently the DCM / TFA mixture is removed in vacuo and the residue is purified by HPLC.
- DCM dichloromethane
- TFA trifluoroacetic acid
- Example 17 The compound from Example 17 (0.1 mmol) is dissolved in 2 ml of dichloromethane (DCM) and 0.1 ml of trifluoroacetic acid (TFA) and stirred at room temperature for 1 h. The DCM / TFA mixture is then removed in vacuo and the residue is purified by HPLC.
- DCM dichloromethane
- TFA trifluoroacetic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Verfahren zur Herstellung von substituierten Thiazol-2-ylmethylestern Process for the preparation of substituted thiazol-2-ylmethyl esters
Die vorliegende Erfindung betrifft ein neues Verfahren zur Herstellung von substituierten Thiazol-2-ylmethyl-estern über eine Multikomponentenreaktion. Diese Verbindungen sind vor allem bei der Synthese von Tubulysinen und Tubulysinderivaten von grossem Interesse.The present invention relates to a new process for the preparation of substituted thiazol-2-ylmethyl esters via a multicomponent reaction. These compounds are of particular interest in the synthesis of tubulysins and tubulysin derivatives.
Thiazol-2 -ylmethylester sind in zahlreichen biologisch aktiven Naturstoffen sowie synthetischen Derivaten wie z. B. Lyngbyabellin A und B, Tubulysinen, Thiostreptonen, Myxothiazolen, Archazolid A, Tallysomycin, Bleomycin, Dysidenin, Dolabellin sowie synthetischen Epothilon- derivaten enthalten (Yokokawa et al. Tetrahedron ett. 2001, 42, 4171-4174; Konishi et al . J. Antibiot 1977, 30, 789-805; Sone et al . J. Org. Chem. 1995, 60, 4774-4781; Kazlauskas et al. Tetrahedron Lett. 1977, 36, 3183-3186) und daher ist ein einfacher und effizienter Zugang zu dieser Substanzklasse insbesondere bei der Synthese von Wirkstoffen von großer Bedeutung .Thiazol-2-methyl esters are found in numerous biologically active natural products as well as synthetic derivatives such as. B. Lyngbyabellin A and B, tubulysins, thiostreptones, myxothiazoles, archazolid A, tallysomycin, bleomycin, dysidenin, dolabellin and synthetic epothilone derivatives (Yokokawa et al. Tetrahedron et al. 2001, 42, 4171-4174; Konishi et al Antibiot 1977, 30, 789-805; Sone et al. J. Org. Chem. 1995, 60, 4774-4781; Kazlauskas et al. Tetrahedron Lett. 1977, 36, 3183-3186) and therefore is simpler and more efficient Access to this class of substances is particularly important in the synthesis of active substances.
Aufgabe der vorliegenden Erfindung war es insbesondere, ein neues Eintopf-Verfahren zur Herstellung dieser Verbindungen bereitzustellen, welches in einer Multi-komponentenreaktion abläuft. Da Multikomponenten-reaktionen sehr variabel sind, eignen sie sich ins-besondere für die Synthese von Substanzbibliotheken zur Auffindung von Leitstrukturen in der pharmazeutischen Industrie (A. Dömling, I. Ugi, Angew. Chem. 2000, 112, 3300-3344) . Ein weiteres Ziel der vorliegenden Erfindung war es, mit Hilfe dieses Verfahrens eine effiziente Synthese zur Verbindungsklasse der Tubulysine bereitzustellen.The object of the present invention was in particular to provide a new one-pot process for the preparation of these compounds, which takes place in a multi-component reaction. Since multicomponent reactions are very variable, they are particularly suitable for the synthesis of substance libraries to find lead structures in the pharmaceutical industry (A. Dömling, I. Ugi, Angew. Chem. 2000, 112, 3300-3344). Another object of the present invention was to use this method to provide an efficient synthesis of the tubulysin class of compounds.
Die Tubulysine wurden erstmals von der Gruppe von Höfle undThe Tubulysins were first developed by the Höfle and
Reichenbach (GBF Braunschweig) aus einer Kulturbrühe vonReichenbach (GBF Braunschweig) from a culture broth from
Stämmen des Myxobakteriums Archangium gephyra isoliertStrains of the Myxobacterium Archangium gephyra isolated
(Sasse et al. J. Antibiot. 2000, 53, 879-885; W09813375;(Sasse et al. J. Antibiot. 2000, 53, 879-885; W09813375;
DE10008089) . Diese Verbindungen haben eine ausgesprochen hohe cytotoxische Aktivität gegenüber Säugetier Zellinien mit IC50-Werten im picomolaren Bereich und sind daher in der Krebsforschung von grossem Interesse. Tubulysine (I) sind Tetrapeptide, die drei ungewöhnliche Aminosäuren enthalten, was ihre Synthese zu einer Herausforderung für die organische Synthesechemie macht.DE10008089). These compounds have an extremely high cytotoxic activity against mammalian cell lines with IC 50 values in the picomolar range and are therefore of great interest in cancer research. Tubulysins (I) are tetrapeptides that contain three unusual amino acids, making their synthesis a challenge for organic synthetic chemistry.
R1 = H , CH20C (O) CH2CH (CH3 ) 2 , CH2OC (0) CH2CH2CH3 , CH20H , CH2OC (0 ) CH3 , CH2OC (0) CH2CH3 , CH2OC (O) CH=C ( CH3 ) 2 ; R2 = H ,R 1 = H, CH 2 0C (O) CH 2 CH (CH 3 ) 2 , CH 2 OC (0) CH 2 CH 2 CH 3 , CH 2 0H, CH 2 OC (0) CH 3 , CH 2 OC ( 0) CH 2 CH 3 , CH 2 OC (O) CH = C (CH 3 ) 2 ; R 2 = H,
OH ; R3 = H , AcOH; R 3 = H, Ac
Alle Definitionen von Resten in der Beschreibung und den Ansprüchen beziehen sich auf alle weiteren gleichlautenden, in der Beschreibung und den Ansprüchen vorkommenden Reste. Die vorliegende Erfindung beschreibt ein neues Verfahren zur Herstellung von Thiazol-2-ylmethylestern der allgemeinen Formel (II) :All definitions of residues in the description and the claims refer to all other identical residues occurring in the description and the claims. The present invention describes a new process for the preparation of thiazol-2-ylmethyl esters of the general formula (II):
worin: wherein:
R4 ein Wasserstoffatom, ein Alkyl-, Alkenyl-, Alkinyl-, Heteroalkyl- , Aryl-, Heteroaryl-, Cycloalkyl-, Alkyl- cycloalkyl-, Heteroalkylcycloalkyl- , Heterocycloalkyl- , Aralkyl- oder ein Heteroaralkylrest ist oder eine Gruppe der Formel COO-L-Pol ist, wobei L ein Linker und Pol ein polymerer Träger ist;R 4 is a hydrogen atom, an alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, heterocycloalkyl, aralkyl or a heteroaralkyl radical or a group of the formula COO -L-Pol is where L is a linker and Pol is a polymeric support;
R5 ein Wasserstoffatom, ein Alkyl-, Alkenyl-, Alkinyl-, Heteroalkyl-, Aryl-, Heteroaryl-, Cycloalkyl-, Alkyl- cycloalkyl-, Heteroalkylcycloalkyl- , Heterocycloalkyl-, Aralkyl- oder ein Heteroaralkylrest ist;R 5 is a hydrogen atom, an alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, heterocycloalkyl, aralkyl or a heteroaralkyl radical;
R6 ein Wasserstoffatom, ein Alkyl-, Alkenyl-, Alkinyl-, Heteroalkyl-, Aryl-, Heteroaryl-, Cycloalkyl-, Alkyl- cycloalkyl-, Heteroalkylcycloalkyl-, Heterocycloalkyl-, Aralkyl- oder ein Heteroaralkylrest ist;R 6 is a hydrogen atom, an alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, heterocycloalkyl, aralkyl or a heteroaralkyl radical;
R7 ein Wasserstoffatom, ein Alkyl-, Alkenyl-, Alkinyl-, Heteroalkyl-, Aryl-, Heteroaryl-, Cycloalkyl-, Alkyl- cycloalkyl- , Heteroalkylcycloalkyl- , Heterocycloalkyl - , Aralkyl- oder ein Heteroaralkylrest ist und R8 ein Wasserstoffatom, ein Alkyl-, Alkenyl-, Alkinyl-, Heteroalkyl-, Aryl-, Heteroaryl-, Cycloalkyl-, Alkyl- cycloalkyl- , Heteroalkylcycloalkyl- , Heterocycloalkyl- , Aralkyl- oder ein Heteroaralkylrest ist.R 7 is a hydrogen atom, an alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, heterocycloalkyl, aralkyl or a heteroaralkyl radical and R 8 is a hydrogen atom, an alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, heterocycloalkyl, aralkyl or a heteroaralkyl radical.
Der Ausdruck Alkyl oder Alk bezieht sich auf eine gesättigte, geradkettige oder verzweigte Kohlenwasser- stoffgruppe, die 1 bis 20 Kohlenstoffatome, vorzugsweise 1 bis 12 Kohlenstoffatome, besonders bevorzugt 1 bis 6 Kohlenstoffatome aufweist, z.B. die Methyl-, Ethyl-, Propyl-, Isopropyl-, Isobutyl-, tert-Butyl, n-Hexyl-, 2, 2-Dimethylbutyl- oder n-Octyl-Gruppe.The term alkyl or alk refers to a saturated, straight-chain or branched hydrocarbon group which has 1 to 20 carbon atoms, preferably 1 to 12 carbon atoms, particularly preferably 1 to 6 carbon atoms, e.g. the methyl, ethyl, propyl, isopropyl, isobutyl, tert-butyl, n-hexyl, 2, 2-dimethylbutyl or n-octyl group.
Die Ausdrücke Alkenyl und Alkinyl beziehen sich auf zumindest teilweise ungesättigte, geradkettige oder verzweigte Kohlenwasserstoffgruppen, die 2 bis 20The terms alkenyl and alkynyl refer to at least partially unsaturated, straight-chain or branched hydrocarbon groups, the 2 to 20
Kohlenstoffatome, vorzugsweise 2 bis 12 Kohlenstoffatome, besonders bevorzugt 2 bis 6 Kohlenstoffatome aufweisen, z.Have carbon atoms, preferably 2 to 12 carbon atoms, particularly preferably 2 to 6 carbon atoms, e.g.
B. die Ethenyl-, Allyl-, Acetylenyl-, Propargyl-, Isoprenyl- oder Hex-2-enyl-Gruppe. Bevorzugt weisen Alkenylgruppen eine oder zwei (besonders bevorzugt eine) Doppelbindungen bzw.B. the ethenyl, allyl, acetylenyl, propargyl, isoprenyl or hex-2-enyl group. Alkenyl groups preferably have one or two (particularly preferably one) double bonds or
Alkinylgruppen eine oder zwei (besonders bevorzugt eine)Alkynyl groups one or two (particularly preferably one)
Dreifachbindungen auf .Triple bonds.
Des weiteren beziehen sich die Begriffe Alkyl, Alkenyl und Alkinyl auf Gruppen, bei der ein oder mehrere Wasserstoffatome durch ein Halogenatom (bevorzugt F oder CD ersetzt sind wie z. B. die 2 , 2, 2-Trichlorethyl-, oder die Trifluormethylgruppe .Furthermore, the terms alkyl, alkenyl and alkynyl refer to groups in which one or more hydrogen atoms have been replaced by a halogen atom (preferably F or CD, such as the 2, 2, 2-trichloroethyl or the trifluoromethyl group).
Der Ausdruck Heteroalkyl bezieht sich auf eine Alkyl-, eine Alkenyl- oder eine Alkinyl-Gruppe, in der ein oder mehrere (bevorzugt 1, 2 oder 3) Kohlenstoffatome durch ein Sauerstoff-, Stickstoff-, Phosphor-, Bor-, Selen-, Silizium- oder Schwefelatom ersetzt sind (bevorzugt Sauerstoff, Schwefel oder Stickstoff) . Der Ausdruck Heteroalkyl bezieht sich des weiteren auf eine Carbonsäuregruppe oder eine von einer Carbonsäure abgeleitete Gruppe wie z. B. Acyl (Alkyl-C0- ) , Acylalkyl, Alkoxycarbonyl , Acyloxy, Acyloxyalkyl, Carboxyalkylamid oder Alkoxycarbonyloxy .The term heteroalkyl refers to an alkyl, an alkenyl or an alkynyl group in which one or more (preferably 1, 2 or 3) carbon atoms are replaced by an oxygen, nitrogen, phosphorus, boron, selenium, silicon or sulfur atom (preferably oxygen, sulfur or nitrogen). The term heteroalkyl also refers to a carboxylic acid group or a group derived from a carboxylic acid, such as, for. B. acyl (alkyl-C0-), acylalkyl, alkoxycarbonyl, acyloxy, acyloxyalkyl, carboxyalkylamide or alkoxycarbonyloxy.
Beispiele für Heteroalkylgruppen sind Gruppen der Formeln R^O-Y*-, R a_s_γ a_# Ra-N (Rb) -Ya- , Ra-CO-Ya-, R-0-CO-Ya- Ra-CO-0-Ya-, Ra-CO-N(Rb) -Ya-, Ra-N(Rb) -CO-Ya-Examples of heteroalkyl groups are groups of the formulas R ^ OY * -, R a _ s _ γ a _ # R a -N (R b ) -Y a -, R a -CO-Y a -, R-0-CO- Y a - R a -CO-0-Y a -, R a -CO-N (R b ) -Y a -, R a -N (R b ) -CO-Y a -
Ra-0-CO-N(Rb) -Ya-, Ra-N(Rb) -CO-0-Ya-, Ra-N (Rb) -CO-N(Rc) -Ya- Ra-0-CO-0-Ya-, Ra-N(Rb) -C(=NRd) -N(RC) -Ya-, Ra-CS-Ya- Ra-0-CS-Ya-, Ra-CS-0-Ya-, Ra-CS-N (Rb) -Ya- , Ra-N (Rb) -CS-Ya- Ra-0-CS-N(Rb) -Ya-, Ra-N(Rb) -CS-0-Ya-, Ra-N (Rb) -CS-N (Rc) -Ya- Ra-0-CS-0-Ya-, Ra-S-CO-Ya-, Ra-CO-S-Ya-, Ra-S-CO-N(Rb) -Ya- Ra-N(Rb) -C0-S-Ya-, Ra-S-CO-0-Ya-, Ra-0-CO-S-Ya- , Ra-S-CO-S-Ya- Ra-S-CS-Ya-, Ra-CS-S-Ya-, Ra-S-CS-N(Rb) -Ya-, R-N (Rb) -CS-S-Ya- Ra-S-CS-0-Ya-, Ra-0-CS-S-Ya-, wobei Ra ein Wasserstoffatom eine d-C6-Alkyl-, eine C2-C6-Alkenyl- oder eine C2-C6- Alkinylgruppe; Rb ein Wasserstoffatom, eine Cx-Ce-Alkyl- , eine C2-C6-Alkenyl- oder eine C2-C3-Alkinylgruppe; Rc ein Wasserstoffatom, eine Cι-C6-Alkyl- , eine C-C6-Alkenyl- oder eine C2-C6-Alkinylgruppe; Rd ein Wasserstoffatom, eine Cι-C6- Alkyl-, eine C2-C6-Alkenyl- oder eine C2-C6-Alkinylgruppe und Ya eine direkte Bindung, eine C].-C6-Alkylen- , eine C2-C6- Alkenylen- oder eine C2-C6-Alkinylengruppe ist, wobei jede Heteroalkylgruppe mindestens ein Kohlenstoffatom enthält und ein oder mehrere Wasserstoffatome durch Fluor- oder Chloratome ersetzt sein können. Konkrete Beispiele für Heteroalkylgruppen sind Methoxy, Trifluormethoxy, Ethoxy, n-Propyloxy, iso-Propyloxy, tert-Butyloxy, Methoxymethyl , Ethoxymethyl , Methoxyethyl , Methylamino, Ethylamino, Di ethylamino, Diethylamino, iso-Propylethylamino, Methyl- aminomethyl, Ethylaminomethyl, Di-iso-Propylaminoethyl, Enolether, Dimethylaminomethyl, Dimethylaminoethyl, Acetyl, Propionyl, Butyryloxy, Acetyloxy, Methoxycarbonyl , Ethoxy- carbonyl, N-Ethyl-N-Methylcarbamoyl oder N-Methylcarbamoyl . Weitere Beispiele für Heteroalkylgruppen sind Nitril-, Isonitril, Cyanat-, Thiocyanat-, Isocyanat-, Isothiocyanat und Alkylnitril-gruppen.R a -0-CO-N (R b ) -Y a -, R a -N (R b ) -CO-0-Y a -, R a -N (R b ) -CO-N (R c ) -Y a - R a -0-CO-0-Y a -, R a -N (R b ) -C (= NR d ) -N (R C ) -Y a -, R a -CS-Y a - R a -0-CS-Y a -, R a -CS-0-Y a -, R a -CS-N (R b ) -Y a -, R a -N (R b ) -CS-Y a - R a -0-CS-N (R b ) -Y a -, R a -N (R b ) -CS-0-Y a -, R a -N (R b ) -CS-N (R c ) -Y a - R a -0-CS-0-Y a -, R a -S-CO-Y a -, R a -CO-SY a -, R a -S-CO-N (R b ) -Y a - R a -N (R b ) -C0-SY a -, R a -S-CO-0-Y a -, R a -0-CO-SY a -, R a -S-CO -SY a - R a -S-CS-Y a -, R a -CS-SY a -, R a -S-CS-N (R b ) -Y a -, RN (R b ) -CS-SY a - R a -S-CS-0-Y a -, R a -0-CS-SY a -, where R a is a hydrogen atom, a dC 6 alkyl, a C 2 -C 6 alkenyl or a C 2 -C 6 alkynyl group; R b represents a hydrogen atom, a Cx-Ce-alkyl, a C 2 -C 6 alkenyl or a C 2 -C 3 alkynyl group; R c is a hydrogen atom, a -C 6 alkyl, a CC 6 alkenyl or a C 2 -C 6 alkynyl group; R d is a hydrogen atom, a Cι-C 6 - alkyl, C 2 -C 6 alkenyl or a C 2 -C 6 alkynyl group and Y a is a direct bond, a C]. Is -C 6 alkylene, a C 2 -C 6 alkenylene or a C 2 -C 6 alkynylene group, each heteroalkyl group containing at least one carbon atom and one or more hydrogen atoms can be replaced by fluorine or chlorine atoms. Specific examples of heteroalkyl groups are methoxy, trifluoromethoxy, ethoxy, n-propyloxy, iso-propyloxy, tert-butyloxy, methoxymethyl, ethoxymethyl, methoxyethyl, methylamino, ethylamino, diethylamino, diethylamino, iso-propylethylamino, methylaminomethyl, ethylaminomethyl, diisopropylaminoethyl, enol ether, dimethylaminoethyl, dimethylaminoethyl, dimethylaminoethyl , Propionyl, butyryloxy, acetyloxy, methoxycarbonyl, ethoxycarbonyl, N-ethyl-N-methylcarbamoyl or N-methylcarbamoyl. Further examples of heteroalkyl groups are nitrile, isonitrile, cyanate, thiocyanate, isocyanate, isothiocyanate and alkyl nitrile groups.
Der Ausdruck Cycloalkyl bezieht sich auf eine gesättigte oder teilweise ungesättigte (z. B. Cycloalkenyl) cyclische Gruppe, die einen oder mehrere Ringe (bevorzugt 1 oder 2) aufweist, welche insgesamt 3 bis 14 Ring-Kohlenstoffatome, vorzugsweise 3 bis 10 (insbesondere 3, 4, 5, 6 oder 7) Ring- Kohlenstoffatome enthalten. Der Ausdruck Cycloalkyl bezieht sich weiterhin auf derartige Gruppen, bei denen ein oder mehrere Wasserstoffatome durch Fluor-, Chlor-, Brom- oder Jodatome oder OH, =0, SH, =S, NH2, =NH oder N02-Gruppen ersetzt sind also z. B. cyclische Ketone wie z. B. Cyclohexanon, 2-Cyclohexenon oder Cyclopentanon. Weitere konkrete Beispiele für Cycloalkylgruppen sind die Cyclopropyl- , Cyclobutyl- , Cyclopentyl- , Spiro [4,5] decanyl- , Norborny-, Cyclohexyl-, Cyclopentenyl- , Cyclohexadienyl- , Decalinyl-, Cubanyl-, Bicyclo [4.3.0] nonyl- , Tetralin-, Cyclopentylcyclohexyl-, Fluorcyclohexyl- oder die Cyclohex- 2 -enyl-Gruppe .The term cycloalkyl refers to a saturated or partially unsaturated (e.g. cycloalkenyl) cyclic group which has one or more rings (preferably 1 or 2) which have a total of 3 to 14 ring carbon atoms, preferably 3 to 10 (especially 3 , 4, 5, 6 or 7) contain ring carbon atoms. The term cycloalkyl also refers to groups in which one or more hydrogen atoms have been replaced by fluorine, chlorine, bromine or iodine atoms or OH, = 0, SH, = S, NH 2 , = NH or NO 2 groups so z. B. cyclic ketones such. B. cyclohexanone, 2-cyclohexenone or cyclopentanone. Further specific examples of cycloalkyl groups are the cyclopropyl, cyclobutyl, cyclopentyl, spiro [4,5] decanyl, norborny, cyclohexyl, cyclopentenyl, cyclohexadienyl, decalinyl, cubanyl, bicyclo [4.3.0] nonyl -, tetralin, cyclopentylcyclohexyl, fluorocyclohexyl or the cyclohex-2-enyl group.
Der Ausdruck Heterocycloalkyl bezieht sich auf eine Cycloalkylgruppe wie oben definiert, in der ein oder mehrere (bevorzugt 1, 2 oder 3) Ring-Kohlenstoffatome durch ein Sauerstoff-, Stickstoff-, Silizium-, Selen-, Phosphor- oder Schwefelatom (bevorzugt Sauerstoff, Schwefel oder Stickstoff) ersetzt sind. Bevorzugt besitzt eine Heterocycloalkylgruppe 1 oder 2 Ringe mit 3 bis 10 (insbesondere 3, 4, 5, 6 oder 7) Ringatomen. Der Ausdruck Heterocycloalkyl bezieht sich weiterhin auf derartige Gruppen, bei denen ein oder mehrere Wasserstoffatome durch Fluor-, Chlor-, Brom- oder Jodatome oder OH, =0, SH, =S, NH2, =NH oder N02-Gruppen ersetzt sind. Beispiele sind die Piperidyl-, Morpholinyl- , Urotropinyl- , Pyrrolidinyl- , Tetrahydrothiophenyl-, Tetrahydropyranyl- , Tetrahydro- furyl-, Oxacyclopropyl- , Azacyclopropyl- oder 2-Pyrazolinyl- Gruppe sowie Lactame, Lactone, cyclische Imide und cyclische Anhydride .The term heterocycloalkyl refers to a cycloalkyl group as defined above in which one or more (preferably 1, 2 or 3) ring carbon atoms are represented by one Oxygen, nitrogen, silicon, selenium, phosphorus or sulfur atom (preferably oxygen, sulfur or nitrogen) are replaced. A heterocycloalkyl group preferably has 1 or 2 rings with 3 to 10 (in particular 3, 4, 5, 6 or 7) ring atoms. The term heterocycloalkyl also relates to groups in which one or more hydrogen atoms have been replaced by fluorine, chlorine, bromine or iodine atoms or OH, = 0, SH, = S, NH 2 , = NH or NO 2 groups , Examples are the piperidyl, morpholinyl, urotropinyl, pyrrolidinyl, tetrahydrothiophenyl, tetrahydropyranyl, tetrahydrofuryl, oxacyclopropyl, azacyclopropyl or 2-pyrazolinyl group as well as lactams, lactones, cyclic imides and cyclic anhydrides.
Der Ausdruck Alkylcycloalkyl bezieht sich auf Gruppen, die entsprechend den obigen Definitionen sowohl Cycloalkyl- wie auch Alkyl-, Alkenyl- oder Alkinylgruppen enthalten, z. B. Alkylcycloalkyl-, Alkylcycloalkenyl- , Alkenylcycloalkyl- und Alkinylcycloalkylgruppen. Bevorzugt enthält eine Alkylcycloalkylgruppe eine Cycloalkylgruppe, die einen oder zwei Ringsysteme aufweist, welche insgesamt 3 bis 10 (insbesondere 3, 4, 5, 6 oder 7) Ring-Kohlenstoffatome enthält und eine oder zwei Alkyl-, Alkenyl- oder Alkinylgruppen mit 1 oder 2 bis 6 Kohlenstoffatomen.The term alkylcycloalkyl refers to groups which, in accordance with the above definitions, contain both cycloalkyl and also alkyl, alkenyl or alkynyl groups, e.g. B. alkylcycloalkyl, alkylcycloalkenyl, alkenylcycloalkyl and alkynylcycloalkyl groups. An alkylcycloalkyl group preferably contains a cycloalkyl group which has one or two ring systems which contain a total of 3 to 10 (in particular 3, 4, 5, 6 or 7) ring carbon atoms and one or two alkyl, alkenyl or alkynyl groups with 1 or 2 up to 6 carbon atoms.
Der Ausdruck Heteroalkylcycloalkyl bezieht sich auf Alkylcycloalkylgruppen, wie oben definiert, in der ein oder mehrere (bevorzugt 1, 2 oder 3) Kohlenstoffatome durch ein Sauerstoff-, Stickstoff-, Silizium-, Selen-, Phosphor- oder Schwefelatom (bevorzugt Sauerstoff, Schwefel oder Stickstoff) ersetzt sind. Bevorzugt besitzt eine Heteroalkylcycloalkylgruppe 1 oder 2 Ringsysteme mit 3 bis 10 (insbesondere 3, 4, 5, 6 oder 7) Ringatomen und eine oder zwei Alkyl, Alkenyl, Alkinyl oder Heteroalkylgruppen mit 1 oder 2 bis 6 Kohlenstoffatomen. Beispiele derartiger Gruppen sind Alkylheterocycloalkyl, Alkylheterocycloalkenyl, Alkenylheterocycloalkyl, Alkinylheterocycloalkyl, Heteroalkylcycloalkyl, Heteroalkylheterocycloalkyl und Hetero- alkylheterocylcloalkenyl, wobei die cyclischen Gruppen gesättigt oder einfach, zweifach oder dreifach ungesättigt sind.The term heteroalkylcycloalkyl refers to alkylcycloalkyl groups, as defined above, in which one or more (preferably 1, 2 or 3) carbon atoms are represented by an oxygen, nitrogen, silicon, selenium, phosphorus or sulfur atom (preferably oxygen, sulfur or Nitrogen) are replaced. Preferably has one Heteroalkylcycloalkyl group 1 or 2 ring systems with 3 to 10 (in particular 3, 4, 5, 6 or 7) ring atoms and one or two alkyl, alkenyl, alkynyl or heteroalkyl groups with 1 or 2 to 6 carbon atoms. Examples of such groups are alkyl heterocycloalkyl, alkyl heterocycloalkenyl, alkenyl heterocycloalkyl, alkynyl heterocycloalkyl, heteroalkylcycloalkyl, heteroalkyl heterocycloalkyl and heteroalkyl heterocylcloalkenyl, the cyclic groups being saturated or mono-, di- or trisaturated.
Der Ausdruck Aryl bzw. Ar bezieht sich auf eine aromatische Gruppe, die einen oder mehrere Ringe hat, die insgesamt 6 bis 14 Ring-Kohlenstoffatome, vorzugsweise 6 bis 10 (insbesondere 6) Ring-Kohlenstoffatome enthalten. Der Ausdruck Aryl (bzw. Ar) bezieht sich weiterhin auf derartige Gruppen, bei denen ein oder mehrere Wasserstoffatome durch Fluor-, Chlor-, Brom- oder Jodatome oder OH, SH, NH2, oder N02-Gruppen ersetzt sind. Beispiele sind die Phenyl-, Naphthyl-, Biphenyl-, 2-Fluorphenyl, Anilinyl-, 3- Nitrophenyl oder 4 -Hydroxyphenyl-Gruppe.The term aryl or Ar refers to an aromatic group which has one or more rings which contain a total of 6 to 14 ring carbon atoms, preferably 6 to 10 (in particular 6) ring carbon atoms. The term aryl (or Ar) also refers to groups in which one or more hydrogen atoms have been replaced by fluorine, chlorine, bromine or iodine atoms or OH, SH, NH 2 or NO 2 groups. Examples are the phenyl, naphthyl, biphenyl, 2-fluorophenyl, anilinyl, 3-nitrophenyl or 4-hydroxyphenyl group.
Der Ausdruck Heteroaryl bezieht sich auf eine aromatische Gruppe, die einen oder mehrere Ringe hat, welche insgesamt das 5 bis 14 Ringatome, vorzugsweise 5 bis 10 (insbesondere 5 oder 6) Ringatome enthalten und ein oder mehrere (bevorzugt 1, 2, 3 oder 4) Sauerstoff-, Stickstoff-, Phosphor- oder Schwefel-Ringatome (bevorzugt O, S oder N) enthalten. Der Ausdruck Heteroaryl bezieht sich weiterhin auf derartige Gruppen, bei denen ein oder mehrere Wasserstoffatome durch Fluor-, Chlor-, Brom- oder Jodatome oder OH, SH, NH2, oder N02-Gruppen ersetzt sind. Beispiele sind 4-Pyridyl-, 2-Imidazolyl- , 3-Phenylpyrrolyl- , Thiazolyl-, Oxazolyl-, Triazolyl-, Tetrazolyl-, Isoxazolyl-, Indazolyl-, Indolyl-, Benzimidazolyl- , Pyridazinyl- , Chinolinyl-, Purinyl-, Carbazolyl-, Acridinyl-, Pyrimidyl-, 2, 3"-Bifuryl-, 3-Pyrazolyl- und Isochinolinyl-Gruppen.The term heteroaryl refers to an aromatic group which has one or more rings which contain a total of 5 to 14 ring atoms, preferably 5 to 10 (in particular 5 or 6) ring atoms and one or more (preferably 1, 2, 3 or 4 ) Contain oxygen, nitrogen, phosphorus or sulfur ring atoms (preferably O, S or N). The expression heteroaryl also refers to groups in which one or more hydrogen atoms have been replaced by fluorine, chlorine, bromine or iodine atoms or OH, SH, NH 2 or NO 2 groups. examples are 4-pyridyl, 2-imidazolyl, 3-phenylpyrrolyl, thiazolyl, oxazolyl, triazolyl, tetrazolyl, isoxazolyl, indazolyl, indolyl, benzimidazolyl, pyridazinyl, quinolinyl, purinyl, carbazolyl , Acridinyl, pyrimidyl, 2, 3 "bifuryl, 3-pyrazolyl and isoquinolinyl groups.
Der Ausdruck Aralkyl bezieht sich auf Gruppen, die entsprechend den obigen Definitionen sowohl Aryl- wie auch Alkyl-, Alkenyl-, Alkinyl- und/oder Cycloalkylgruppen enthalten, wie z. B. Arylalkyl-, Arylalkenyl- , Arylalkinyl- , Arylcyclo- alkyl-, Arylcycloalkenyl- , Alkylarylcycloalkyl- und Alkyl- arylcycloalkenylgruppen. Konkrete Beispiele für Aralkyle sind Toluol, Xylol, Mesitylen, Styrol, Benzylchlorid, o- Fluortoluol, lH-Inden, Tetralin, Dihydronaphthaline, Indanon, Phenylcyclopentyl, Cumol, Cyclo-hexylphenyl, Fluoren und Indan. Bevorzugt enthält eine Aralkylgruppe ein oder zwei aromatische Ringsysteme (1 oder 2 Ringe) mit insgesamt 6 bis 10 Ring-Kohlenstoffatomen und ein oder zwei Alkyl-, Alkenyl- und/oder Alkinylgruppen mit 1 oder 2 bis 6 Kohlenstoffatomen und/oder eine Cyclo-alkylgruppe mit 5 oder 6 Ringkohlenstoffatomen.The term aralkyl refers to groups which, according to the above definitions, contain both aryl and also alkyl, alkenyl, alkynyl and / or cycloalkyl groups, such as, for. B. arylalkyl, arylalkenyl, arylalkynyl, arylcycloalkyl, arylcycloalkenyl, alkylarylcycloalkyl and alkyl arylcycloalkenyl groups. Specific examples of aralkyls are toluene, xylene, mesitylene, styrene, benzyl chloride, o-fluorotoluene, 1H-indene, tetralin, dihydronaphthalenes, indanone, phenylcyclopentyl, cumene, cyclo-hexylphenyl, fluorene and indane. An aralkyl group preferably contains one or two aromatic ring systems (1 or 2 rings) with a total of 6 to 10 ring carbon atoms and one or two alkyl, alkenyl and / or alkynyl groups with 1 or 2 to 6 carbon atoms and / or a cycloalkyl group with 5 or 6 ring carbon atoms.
Der Ausdruck Heteroaralkyl bezieht sich auf eine Aralkylgruppe wie oben definiert, in der ein oder mehrere (bevorzugt 1, 2, 3 oder 4) Kohlenstoffatome durch ein Sauerstoff-, Stickstoff-, Silizium-, Selen-, Phosphor-, Boroder Schwefelatom (bevorzugt Sauerstoff, Schwefel oder Stickstoff) ersetzt sind, d. h. auf Gruppen, die entsprechend den obigen Definitionen sowohl Aryl- bzw. Heteroaryl- wie auch Alkyl-, Alkenyl-, Alkinyl- und/oder Heteroalkyl- und/oder Cycloalkyl- und/oder Heterocyclo- alkylgruppen enthalten. Bevorzugt enthält eine Heteroaralkylgruppe ein oder zwei aromatische Ringsysteme (l oder 2 Ringe) mit insgesamt 5 oder 6 bis 10 Ring- Kohlenstoffatomen und ein oder zwei Alkyl-, Alkenyl- und/oder Alkinylgruppen mit 1 oder 2 bis 6 Kohlenstoffatomen und/oder eine Cycloalkylgruppe mit 5 oder 6 Ringkohlenstoffatomen, wobei 1, 2, 3 oder 4 dieser Kohlenstoffatome durch Sauerstoff-, Schwefel- oder Stickstoffatome ersetzt sind.The term heteroaralkyl refers to an aralkyl group as defined above in which one or more (preferably 1, 2, 3 or 4) carbon atoms are represented by an oxygen, nitrogen, silicon, selenium, phosphorus, boron or sulfur atom (preferably oxygen , Sulfur or nitrogen) are replaced, ie on groups which, according to the above definitions, are both aryl or heteroaryl and also alkyl, alkenyl, alkynyl and / or heteroalkyl and / or cycloalkyl and / or heterocycloalkyl groups contain. Preferably contains one Heteroaralkyl group one or two aromatic ring systems (1 or 2 rings) with a total of 5 or 6 to 10 ring carbon atoms and one or two alkyl, alkenyl and / or alkynyl groups with 1 or 2 to 6 carbon atoms and / or a cycloalkyl group with 5 or 6 ring carbon atoms, 1, 2, 3 or 4 of these carbon atoms being replaced by oxygen, sulfur or nitrogen atoms.
Beispiele sind Arylheteroalkyl- , Arylheterocycloalkyl- , Arylheterocycloalkenyl- , Arylalkylheterocycloalkyl- , Arylal- kenylheterocycloalkyl- , Arylalkinylheterocyclo-alkyl- , Aryl- alkylheterocycloalkenyl- , Heteroarylalkyl- , Heteroarylalke- nyl-, Heteroarylalkinyl- , Heteroarylheteroalkyl- , Hetero- arylcycloalkyl-, Heteroarylcycloalkenyl- , Heteroarylhetero- cycloalkyl-, Heteroarylheterocycloalkenyl- , Heteroarylal- kylcycloalkyl- , Heteroarylalkylheterocycloalkenyl- , Hetero- arylheteroalkylcycloalkyl- , Heteroarylheteroalkylcycloalke- nyl- und Heteroarylheteroalkylheterocycloalkyl -Gruppen, wo- bei die cyclischen Gruppen gesättigt oder einfach, zweifach oder dreifach ungesättigt sind. Konkrete Beispiele sind die Tetrahydroisochinolinyl-, Benzoyl-, 2- oder 3-Ethylindolyl- , 4-Methylpyridino- , 2-, 3- oder 4-Methoxyphenyl- , 4-Ethoxyphenyl-, 2-, 3- oder 4-Carboxyphenylalkylgruppe .Examples are aryl heteroalkyl, aryl heterocycloalkyl, aryl heterocycloalkenyl, aryl alkyl heterocycloalkyl, aryl alkenyl heterocycloalkyl, arylalkynyl heterocyclo alkyl, aryl alkyl heterocycloalkenyl, heteroaryl alkyl, hetero aryl hetero aryl hetero aryl , Heteroarylhetero- cycloalkyl-, Heteroarylheterocycloalkenyl-, Heteroarylal- kylcycloalkyl-, Heteroarylalkylheterocycloalkenyl-, arylheteroalkylcycloalkyl- hetero-, Heteroarylheteroalkylcycloalke- nyl- and Heteroarylheteroalkylheterocycloalkyl groups, WO at the cyclic groups being saturated or mono-, di- or tri-unsaturated. Specific examples are the tetrahydroisoquinolinyl, benzoyl, 2- or 3-ethylindolyl, 4-methylpyridino, 2-, 3- or 4-methoxyphenyl, 4-ethoxyphenyl, 2-, 3- or 4-carboxyphenylalkyl group.
Die Ausdrücke Cycloalkyl, Heterocycloalkyl, Alkylcycloalkyl, Heteroalkylcycloalkyl, Aryl, Heteroaryl, Aralkyl und Heteroaralkyl beziehen sich auch auf Gruppen, in denen ein oder mehrere Wasserstoffatome solcher Gruppen durch Fluor-, Chlor-, Brom- oder Jodatome oder OH, =0, SH, =S, NH2, =NH oder N02-Gruppen ersetzt sind. Der Ausdruck "gegebenenfalls substituiert" bezieht sich auf Gruppen, in denen ein oder mehrere WasserStoffatome durch Fluor-, Chlor-, Brom- oder Jodatome oder OH, =0, SH, =S, NH2, =NH oder N02-Gruppen ersetzt sind. Dieser Ausdruck bezieht sich weiterhin auf Gruppen, die ausschließlich oder zusätzlich mit unsubstituierten Cι-C6 Alkyl-, C2-C6 Alkenyl-, C2-C6 Alkinyl-, Cι-C6 Heteroalkyl-, C3-Cι0 Cycloalkyl-, C2-C9 Heterocycloalkyl-, C6-Cι0 Aryl-, Cι-C9 Heteroaryl-, C7-Cι2 Aralkyl- oder C2-Cn Heteroaralkyl-Gruppen substituiert sind.The terms cycloalkyl, heterocycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, aryl, heteroaryl, aralkyl and heteroaralkyl also refer to groups in which one or more hydrogen atoms of such groups are represented by fluorine, chlorine, bromine or iodine atoms or OH, = 0, SH, = S, NH 2 , = NH or N0 2 groups are replaced. The term "optionally substituted" refers to groups in which one or more hydrogen atoms are replaced by fluorine, chlorine, bromine or iodine atoms or OH, = 0, SH, = S, NH 2 , = NH or NO 2 groups are. This expression also relates to groups which exclusively or additionally with unsubstituted -CC 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, -C-C 6 heteroalkyl, C 3 -Cι 0 cycloalkyl -, C 2 -C 9 heterocycloalkyl, C 6 -Cι 0 aryl, -C-C 9 heteroaryl, C 7 -Cι 2 aralkyl or C 2 -Cn heteroaralkyl groups are substituted.
Verbindungen der Formel (I) können aufgrund ihrer Substitution ein oder mehrere Chiralitätszentren enthalten. Die vorliegende Erfindung umfasst daher sowohl alle reinen Enantiomere und alle reinen Diastereomere, als auch deren Gemische in jedem Mischungsverhältnis. Des weiteren sind von der vorliegenden Erfindung auch alle cis/trans-Isomeren der Verbindungen der allgemeinen Formel (I) sowie Gemische davon umfasst. Des weiteren sind von der vorliegenden Erfindung alle tautomeren Formen der Verbindungen der Formel (I) umfasst .Compounds of formula (I) can contain one or more centers of chirality due to their substitution. The present invention therefore encompasses all pure enantiomers and all pure diastereomers, as well as their mixtures in any mixing ratio. Furthermore, the present invention also includes all cis / trans isomers of the compounds of the general formula (I) and mixtures thereof. The present invention further encompasses all tautomeric forms of the compounds of the formula (I).
Der Ausdruck Linker bezieht sich auf eine Gruppe, die dazu geeignet ist, Moleküle mit einem polymeren Träger zu verbinden. Ein Linker kann eine Alkyl-, Heteroalkyl-, Aryl-, Heteroaryl-, Cycloalkyl-, Heterocycloalkyl-, Aralkyl- oder ein Heteroaralkylgruppe sein. Beispiele für Linker sind in P. Seneci, Solid-Phase Synthesis and Combinatorial Technologies, John Wiley & Sons, New York, 2000; D. Obrecht und J. M. Villalgordo, Solid-Supported Combinatorial and Parallel Synthesis of Small-Molecular-Weight Compound Libraries, Tetrahedron Organic-Chemistry Series Volume 17, Elsevier Science Ltd, Oxford, 1998 sowie in F. Z. Dörwald, Organic Synthesis on Solid Phase, Wiley-VCH, Weinheim, 2000 beschrieben, welche Beispiele hier unter Bezugnahme aufgenommen sind. Beispielhaft seien hier der Trityllinker, der Wang-Linker, der SASRIN™-Linker, der Rink-Säure-Linker, der Benzhydrylalkohol-Linker, der HMBA-Linker sowie polymeres Benzylhalogenid (Linker des Merrifield Harzes) sowie der PAM-Linker genannt.The term linker refers to a group that is suitable for connecting molecules to a polymeric support. A linker can be an alkyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, aralkyl or a heteroaralkyl group. Examples of linkers are found in P. Seneci, Solid-Phase Synthesis and Combinatorial Technologies, John Wiley & Sons, New York, 2000; D. Obrecht and JM Villalgordo, Solid-Supported Combinatorial and Parallel Synthesis of Small-Molecular-Weight Compound Libraries, Tetrahedron Organic-Chemistry Series Volume 17, Elsevier Science Ltd, Oxford, 1998 and in FZ Dörwald, Organic Synthesis on Solid Phase, Wiley-VCH, Weinheim, 2000, which examples are included here with reference. Examples include the trityl linker, the Wang linker, the SASRIN ™ linker, the Rink acid linker, the benzhydryl alcohol linker, the HMBA linker and polymeric benzyl halide (linker of the Merrifield resin) and the PAM linker.
Der Ausdruck polymerer Träger bezieht sich auf ein Polymer das für die organische Festphasensynthese modifiziert wurde. Beispiele für polymere Träger sind in P. Seneci, Solid-Phase Synthesis and Combinatorial Technologies, John Wiley & Sons, New York, 2000; D. Obrecht und J. M. Villalgordo, Solid- Supported Combinatorial and parallel Synthesis of Small- Molecular-Weight Compound Libraries, Tetrahedron Organic- Chemistry Series Volume 17, Elsevier Science Ltd, Oxford, 1998 sowie in F. Z. Dörwald, Organic Synthesis on Solid Phase, Wiley-VCH, Weinheim, 2000 beschrieben, welche Beispiele hier unter Bezugnahme aufgenommen sind. Es wird zwischen löslichen und unlöslichen polymeren Trägern unterschieden. Beispiele für lösliche polymere Träger sind die Polyethylenglycole (PEG) . Beispiele für unlösliche polymere Träger sind Polymere auf Polystyrol-Basis (vernetzt mit Divinylbenzol) wie z. B. das Merrifield Harz, Bromo- (4- methoxyphenyDmethyl Polystyrrol, 4- (Bromomethyl)phenoxy- ethyl Polystyrrol, das 2-Clorotrityl Harz, Tentakel -Polymere wie z.B. Tentagel®, Kieselgel, Controlled Pore Glass (CPG) , Cellulose, Copolymere und Gold. Polymere Träger, sowie durch Linker modifizierte polymere Träger, sind bei einer Reihe von Firmen wie z. B. Calbiochem-Novabiochem AG, Laufelfingen, Schweiz, Bachern AG, Bubendorf, Schweiz, Rapp Polymere GmbH, Tübingen, Deutschland, Advanced ChemTech, Louisville, KY, USA sowie Shearwater Corporation, Huntsville, Alabama, USA kommerziell erhältlich.The term polymeric carrier refers to a polymer that has been modified for organic solid phase synthesis. Examples of polymeric supports are described in P. Seneci, Solid-Phase Synthesis and Combinatorial Technologies, John Wiley & Sons, New York, 2000; D. Obrecht and JM Villalgordo, Solid-Supported Combinatorial and parallel Synthesis of Small- Molecular-Weight Compound Libraries, Tetrahedron Organic- Chemistry Series Volume 17, Elsevier Science Ltd, Oxford, 1998 and in FZ Dörwald, Organic Synthesis on Solid Phase, Wiley -VCH, Weinheim, 2000, which examples are included here with reference. A distinction is made between soluble and insoluble polymeric carriers. Examples of soluble polymeric carriers are the polyethylene glycols (PEG). Examples of insoluble polymeric supports are polymers based on polystyrene (crosslinked with divinylbenzene) such as. As the Merrifield resin, bromo (4- methoxyphenyDmethyl Polystyrrol, 4- (bromomethyl) phenoxy ethyl Polystyrrol, the 2-Clorotrityl resin tentacle polymers such as Tentagel ®, silica gel, controlled pore glass (CPG), cellulose, copolymers and gold.Polymeric carriers, as well as polymeric carriers modified by linkers, are available from a number of companies such as Calbiochem-Novabiochem AG, Laufelfingen, Switzerland, Bachern AG, Bubendorf, Switzerland, Rapp Polymer GmbH, Tübingen, Germany, Advanced ChemTech . Louisville, KY, USA and Shearwater Corporation, Huntsville, Alabama, USA are commercially available.
Schutzgruppen sind dem Fachmann bekannt und z. B. in P. J. Kocienski, Protecting Groups, Georg Thieme Verlag, Stuttgart, 1994 sowie in T. W. Greene, P. G. M. Wuts, Protective Groups in Organic Synthesis, John Wiley & Sons, New York, 1999 beschrieben, welche Beispiele hier unter Bezugnahme aufgenommen sind. Gängige Aminoschutzgruppen sind z. B. t-Butyloxycarbonyl- (Boc) , Benzyloxycarbonyl - (Cbz, Z) , Benzyl- (Bn) , Benzoyl- (Bz) , Fluorenylmethyloxycarbonyl- (Fmoc) , Allyloxycarbonyl - (Alloc) , Trichlorethyloxycarbonyl- (Troc) , Acetyl- oder Trifluoracetylgruppen.Protecting groups are known to the expert and z. B. in P. J. Kocienski, Protecting Groups, Georg Thieme Verlag, Stuttgart, 1994 and in T. W. Greene, P. G. M. Wuts, Protective Groups in Organic Synthesis, John Wiley & Sons, New York, 1999, which examples are incorporated herein by reference. Common amino protecting groups are e.g. B. t-Butyloxycarbonyl- (Boc), Benzyloxycarbonyl- (Cbz, Z), Benzyl- (Bn), Benzoyl- (Bz), Fluorenylmethyloxycarbonyl- (Fmoc), Allyloxycarbonyl- (Alloc), Trichlorethyloxycarbonyl- (Troc), Acetyl- or trifluoroacetyl groups.
Die erfindungsgemäßen Verbindungen können durch die Umsetzung von Verbindungen der Formeln (III) , (IV) und (V) hergestellt werden,The compounds according to the invention can be prepared by reacting compounds of the formulas (III), (IV) and (V)
ll) (IV) (V) ll) (IV) (V)
worin X eine Abgangsgruppe wie z. B. F, Cl, Br, I, NR 9bτR-,10 OR11 oder SOnR12 ist, worin R9, R10, R11 und R12 unabhängig voneinander ein Wasserstoffatom, ein Alkyl, Heteroalkyl-, Aryl-, Aralkyl-, Cycloalkyl-, Cycloaralkyl- , Heterocyclo- alkyl-, Heteroaralkyl-, oder ein Heteroarylrest sind und n = 0, 1, 2 oder 3 ist. Durch geeignete Wahl der Reaktionsbedingungen (z. B. Zugabe von Ammoniak in Methanol) lassen sich direkt Verbindungen der Formel (Ha) herstellen:where X is a leaving group such. B. F, Cl, Br, I, NR 9 b τR-, 10 OR 11 or SO n R 12 , wherein R 9 , R 10 , R 11 and R 12 are independently a hydrogen atom, an alkyl, heteroalkyl, aryl - Aralkyl, cycloalkyl, cycloaralkyl, heterocycloalkyl, heteroaralkyl, or a heteroaryl radical and n = 0, 1, 2 or 3. By suitable choice of the reaction conditions (e.g. addition of ammonia in methanol), compounds of the formula (Ha) can be prepared directly:
Gemäß einer bevorzugten Ausfuhrungsform ist R4 eine Gruppe der Formel COOR13, eine Pyridylgruppe oder eine Gruppe der Formel S02Aryl, wobei R13 eine Alkylgruppe oder eine Gruppe der Formel -L-Pol ist wobei L ein Linker und Pol ein polymerer Träger ist.According to a preferred embodiment, R 4 is a group of the formula COOR 13 , a pyridyl group or a group of the formula S0 2 aryl, where R 13 is an alkyl group or a group of the formula -L-Pol where L is a linker and Pol is a polymeric carrier ,
Besonders bevorzugt ist R4 eine Gruppe der Formel COOMe, COOEt oder COO'Εu.R 4 is particularly preferably a group of the formula COOMe, COOEt or COO'Εu.
Gemäß einer weiteren bevorzugten Ausfuhrungsform ist R5 ein Wasserstoffatom.According to a further preferred embodiment, R 5 is a hydrogen atom.
Des weiteren bevorzugt ist R6 ein Wasserstoffatom.R 6 is furthermore preferably a hydrogen atom.
Des weiteren bevorzugt ist R7 ein Cι-C6-Alkyl- , C2-C6- Alkenyl-, C2-C6-Alkinyl- , Cι-C5-Heteroalkyl- , C6- oder Cι0- Aryl-, C5-C9-Heteroaryl- , C3-Cι0-Cycloalkyl- , C4-Cn- Alkylcycloalkyl-, C3-Cι0-Heteroalkylcycloalkyl- , C2-C9- Heterocycloalkyl-, C7-C12-Aralkyl- oder ein C5-Cι2- Heteroaralkylres ,Further preferably R 7 is a Cι-C 6 alkyl, C 2 -C 6 - alkenyl, C 2 -C 6 alkynyl, Cι-C5 heteroalkyl, C 6 - or Cι 0 - aryl , C 5 -C 9 heteroaryl-, C 3 -Cι 0 cycloalkyl-, C 4 -C n - alkylcycloalkyl-, C 3 -Cι 0 heteroalkylcycloalkyl-, C 2 -C 9 - heterocycloalkyl-, C 7 -C 12 aralkyl or a C 5 -C 2 heteroaralkylres,
wobei der Rest R7 in beta-Stellung zum Thiazolring vorzugsweise kein Wasserstoffatom oder Heteroatom aufweist. Weiter bevorzugt ist X eine Gruppe der Formel NMe2.wherein the radical R 7 in the beta position relative to the thiazole ring preferably has no hydrogen atom or hetero atom. X is more preferably a group of the formula NMe 2 .
Bevorzugt werden die Umsetzungen in einem aprotischen Lösungsmittel wie z. B. Tetrahydrofuran (THF) , Dioxan, Diethylether, Acetonitril oder Methylenchlorid durchgeführt, wobei Ether wie z. B. THF besonders bevorzugt sind.The reactions in an aprotic solvent such as. B. tetrahydrofuran (THF), dioxane, diethyl ether, acetonitrile or methylene chloride, with ethers such as. B. THF are particularly preferred.
Bevorzugt werden die Verbindungen (III) , (IV) und (V) äquimolar eingesetzt.The compounds (III), (IV) and (V) are preferably used in equimolar amounts.
Des weiteren bevorzugt werden die Umsetzungen unter einer Inertgasatmosphäre (z. B. N2, Ar) durchgeführt.Furthermore, the reactions are preferably carried out under an inert gas atmosphere (for example N 2 , Ar).
Die bevorzugte Reaktionstemperaturen liegen im Bereich von - 100°C bis 100°C, wobei Reaktionstemperaturen von -80°C bis 60°C besonders bevorzugt sind (besonders bevorzugt sind Temperaturen von -25°C bis 25°C) . Gegebenenfalls wird die Reaktion in einem Mikrowellenreaktor durchgeführt .The preferred reaction temperatures are in the range from -100 ° C. to 100 ° C., reaction temperatures from -80 ° C. to 60 ° C. being particularly preferred (temperatures from -25 ° C. to 25 ° C. are particularly preferred). The reaction is optionally carried out in a microwave reactor.
Gegebenenfalls kann bei der Reaktion die Zugabe einer Lewis- Säure wie z. B. Bortrifluoridetherat , Trimethyl-aluminium, Lithiumchlorid, Aluminiumtrichlorid, Zinkchlorid (ZnCl3) , Ytterbiumtriflat, Magnesiumtriflat , Magnesiumbromid, Zirkoniumchlorid (ZrCl4) , Titan (IV) Chlorid, Zinktriflat (Zn(OTf)2), Scandiumtriflat (Sc(OTf)3), Hafniumtriflat (Hf (OTf)4) oder Zinntetrachlorid bevorzugt sein.Optionally, the addition of a Lewis acid such as. B. boron trifluoride etherate, trimethyl aluminum, lithium chloride, aluminum trichloride, zinc chloride (ZnCl 3 ), ytterbium triflate, magnesium triflate, magnesium bromide, zirconium chloride (ZrCl 4 ), titanium (IV) chloride, zinc triflate (Zn (OTf) 2 ), scandium triflate (Sc (triflate) ) 3 ), hafnium triflate (Hf (OTf) 4 ) or tin tetrachloride may be preferred.
Weiter bevorzugt wird Verbindung (III) zuerst mit der Lewis- Säure in dem Lösungsmittel gelöst und anschliessend (bevorzugt nach 5 bis 30 Minuten) Verbindungen (IV) und (V) zugegeben . Eine Schlüsselverbindung bei der Synthese einiger der oben beschriebenen Tubulysinderivate ist ein Aminosäurederivat der allgemeinen Formel (VI) :More preferably, compound (III) is first dissolved in the solvent with the Lewis acid and then (preferably after 5 to 30 minutes) compounds (IV) and (V) are added. A key compound in the synthesis of some of the tubulysin derivatives described above is an amino acid derivative of the general formula (VI):
Diese Verbindung kann mit dem hier beschriebenen Verfahren auf einfache Weise durch Umsetzung von Verbindungen der Formeln (IV) , (VII) und (VIII) synthetisiert werden,This compound can be synthesized in a simple manner using the process described here by reacting compounds of the formulas (IV), (VII) and (VIII)
wobei PG eine Aminoschutzgruppe und R14 ein Wasserstoffatom, ein Alkyl- oder ein Heteroalkylrest ist. Dieses Verfahren wird von der vorliegenden Erfindung ebenfalls umfasst.where PG is an amino protecting group and R 14 is a hydrogen atom, an alkyl or a heteroalkyl radical. This method is also encompassed by the present invention.
Bevorzugt ist PG eine Boc-Gruppe, R ein Wasserstoffatom undPG is preferably a Boc group, R is a hydrogen atom and
R 13 eine Methyl-, eine Ethyl- oder eine tert-Butyl-gruppe. Die Synthese von Verbindungen der Formeln (III) bzw. (VIII) ist z. B. in Schöllkopf et al . Liebigs Ann. Chem. 1979, 1444-1446 beschrieben.R 13 is a methyl, an ethyl or a tert-butyl group. The synthesis of compounds of the formulas (III) or (VIII) is, for. B. in Schöllkopf et al. Liebigs Ann. Chem. 1979, 1444-1446.
Verbindungen der Formel (IV) sind kommerziell erhältlich.Compounds of formula (IV) are commercially available.
α-Aminothiosäuren der Formel (V) können z. B. nach dem in Wieland et al . Chem. Ber. 1958, 91, 2305-2308 beschriebenen Verfahren hergestellt werden und sind z. Teil auch kommerziell erhältlich.α-Aminothioacids of the formula (V) z. B. after the in Wieland et al. Chem. Ber. 1958, 91, 2305-2308 described methods are prepared and are, for. Some also commercially available.
Verbindungen der Formel (VII) können z. B. über eine α-Aminoalkylierung aus Isobutyraldehyd, Ammoniumacetat oder einem primären Amin bzw. dessen Hydrochlorid und Malonsäure hergestellt werden. Die dabei entstehende ß-Aminosäure wird anschliessend gegebenenfalls N-alkyliert (z. B. durch Reduktive Aminierung) und anschliessend mit einer Schutzgruppe (z. B. t-Butyloxycarbonyl, Boc) versehen. Danach wird die Säuregruppe nach Standartvorschriften in den Aldehyd überführt (siehe z. B. R. C. Larock, Comprehensive Organic Transformations, VCH Publishers, New York, 1989) . Alternativ kann die ß-Aminosäure auch über eine Arndt- Eistert-Reaktion aus Valin hergestellt werden.Compounds of formula (VII) z. B. via an α-aminoalkylation from isobutyraldehyde, ammonium acetate or a primary amine or its hydrochloride and malonic acid. The resulting ß-amino acid is then optionally N-alkylated (e.g. by reductive amination) and then provided with a protective group (e.g. t-butyloxycarbonyl, Boc). The acid group is then converted into the aldehyde according to standard regulations (see, for example, R.C. Larock, Comprehensive Organic Transformations, VCH Publishers, New York, 1989). Alternatively, the β-amino acid can also be produced from valine via an Arndt-Eistert reaction.
Gemäß einer weiteren bevorzugte Ausfuhrungsform wird als Thiocarbonsäure (allgemeine Formel IV) ein Isoleucin-derivat der Formel (IX) verwendet, According to a further preferred embodiment, an isoleucine derivative of the formula (IX) is used as the thiocarboxylic acid (general formula IV),
wobei PG' eine Aminoschutzgruppe (bevorzugt Boc) ist. Bei dieser Ausfuhrungsform gelangt man zu Verbindungen der Formel (X) ,where PG 'is an amino protecting group (preferably Boc). In this embodiment, compounds of the formula (X)
die nach Abspaltung der Schutzgruppen PG und PG' durch Umlagerung in Verbindung (XI) umgewandelt werden kann.which after splitting off the protective groups PG and PG 'can be converted by rearrangement in compound (XI).
Die Synthese von Tubulysinen der Formel (I) kann über folgende Schritte ausgehend von Verbindung (XI) durchgeführt werden : Kupplung mit N-Pipecolinsäure zu Verbindung (XII)The synthesis of tubulysins of the formula (I) can be carried out using the following steps starting from compound (XI): Coupling with N-pipecolic acid to compound (XII)
Entschützung der Carbonsäure zu einer Verbindung (XII) mit R13 = H.Deprotection of the carboxylic acid to a compound (XII) with R 13 = H.
Kupplung mit dem in DE 10008089 beschrieben Aminosäurederivat und anschliessende Entschützung der Carbonsäure zu Verbindung (XIII) (R2 = H oder OH)Coupling with the amino acid derivative described in DE 10008089 and subsequent deprotection of the carboxylic acid to give compound (XIII) (R 2 = H or OH)
Umsetzung von Verbindung (XIII) zu Verbindung (XIV) (z. B. mit Paraformaldehyd in Gegenwart einer Säure) und anschliessende Öffnung des Sechsrings mit einem Carbonsäureanion (z. B. (CH3) 2CHCH2COO", CH3CH2CH2COO" , CH3COO", CH3CH2COO", (CH3)2C=CHCOO") zu einer Verbindung der Formel (I) mit R1 = CH2OC(0)R15, wobei R15 eine Alkylgruppe ist. Conversion of compound (XIII) to compound (XIV) (e.g. with paraformaldehyde in the presence of an acid) and subsequent opening of the six-membered ring with a carboxylic acid anion (e.g. (CH 3 ) 2 CHCH 2 COO " , CH 3 CH 2 CH 2 COO " , CH 3 COO " , CH 3 CH 2 COO " , (CH 3 ) 2 C = CHCOO " ) to a compound of the formula (I) with R 1 = CH 2 OC (0) R 15 , where R 15 is an alkyl group.
BeispieleExamples
Allgemeine Arbeitsvorschrift 1:General working instructions 1:
1 mmol der Carbonylverbinung (IV) wird in 3 ml abs . THF gelöst und 1 mmol Bortrifluoridetherat zugegeben. Diese Mischung wird nach 10 min mit 1 mmol des Isonitrils (III) und 1 mmol der Thiocarbonsäure (V) versetzt und die Mischung 72h gerührt . Zur Aufarbeitung wird Wasser zugegeben und gegebenenfalls über Celite abfiltriert. Dann wird zur Trockne einrotiert, in Ethylacetat aufgenommen und zweimal mit Wasser ausgeschüttelt. Nach dem Trocknen der organischen Phase über Natriumsulfat wird zur Trockne einrotiert. Der Rückstand wird mittels präparativer HPLC gereinigt (Reversed Phase-C18-Phase, Eluent Methanol+0.5%Essigsäure / Wasser+0.5% Essigsäure).1 mmol of the carbonyl compound (IV) is abs. In 3 ml. THF dissolved and 1 mmol of boron trifluoride etherate added. After 10 min, 1 mmol of the isonitrile (III) and 1 mmol of the thiocarboxylic acid (V) are added to this mixture, and the mixture is stirred for 72 h. For working up, water is added and, if appropriate, filtered off through Celite. The mixture is then evaporated to dryness, taken up in ethyl acetate and extracted twice with water. After the organic phase has been dried over sodium sulfate, the mixture is evaporated to dryness. The residue is purified by preparative HPLC (reversed phase C18 phase, eluent methanol + 0.5% acetic acid / water + 0.5% acetic acid).
Allgemeine Arbeitsvorschrift 2: 3 mmol der Aldehyd-Komponente (IV) werden unter inertenGeneral procedure 2: 3 mmol of the aldehyde component (IV) are under inert
Bedingungen (Stickstoffatmosphäre) in 6 ml trockenem THF gelöst und auf -18°C gekühlt. Anschließend werden 3 mmolConditions (nitrogen atmosphere) dissolved in 6 ml of dry THF and cooled to -18 ° C. Then 3 mmol
(378 μl) Bortrifluoridetherat zugegeben und 5 min gerührt. 3 mmol (462 mg) Isocyanid (III) und 3 mmol Thiosäure (V) werden hinzugefügt und die Reaktionsmischung noch weitere 30 min bei -18°C gerührt. Man lässt auf RT erwärmen und rührt weitere 18 h.(378 μl) boron trifluoride etherate added and stirred for 5 min. 3 mmol (462 mg) isocyanide (III) and 3 mmol thioic acid (V) are added and the reaction mixture a further 30 min at -18 ° C stirred. The mixture is allowed to warm to RT and stirred for a further 18 h.
Nach 18 h wird die Reaktion mit 6 ml Wasser hydrolysiert und mit 6 ml Ethylacetat versetzt. Die wässrige Phase wird abgetrennt und die organische Phase noch 3x mit je 3 ml gesättigter Natriumhydrogencarbonat-Lösung, 3x mit je 3 ml 5% Citronensäure und 2x mit je 3 ml gesättigter Natriumchlorid-Lösung gewaschen. Die Ethylacetatphase Phase wird über Natriumsulfat getrocknet und einrotiert. Die Reiniung des Rohproduktes erfolgt mittels Chromatotrographie .After 18 h, the reaction is hydrolyzed with 6 ml of water and mixed with 6 ml of ethyl acetate. The aqueous phase is separated off and the organic phase is washed 3 times with 3 ml of saturated sodium hydrogen carbonate solution, 3 times with 3 ml of 5% citric acid and 2 times with 3 ml of saturated sodium chloride solution. The ethyl acetate phase is dried over sodium sulfate and evaporated. The raw product is purified by means of chromatotrography.
Beispiel 1example 1
C14Η12N206S ( 336 . 3255 ) MS (ESI ) : 337 [M+H]C 14 Η 12 N 2 0 6 S (336. 3255) MS (ESI): 337 [M + H]
Beispiel 2Example 2
C16Hι7N04S (319 . 3822 ) MS (ESI) : 320 [M+H]C 16 Hι 7 N0 4 S (319.3822) MS (ESI): 320 [M + H]
Beispiel 3Example 3
Cι2H17N04S (271.3376) MS (ESI) : 272 [M+H]Cι 2 H 17 N0 4 S (271.3376) MS (ESI): 272 [M + H]
Beispiel 4Example 4
C14H19N04S (297.3758) MS (ESI) : 298 [M+H]C 14 H 19 N0 4 S (297.3758) MS (ESI): 298 [M + H]
Beispiel 5Example 5
C13H19N04S (285.3647) MS (ESI) : 286 [M+H] Beispiel 6;C 13 H 19 N0 4 S (285.3647) MS (ESI): 286 [M + H] Example 6;
Cι2H17N04S (271.3376) MS (ESI) : 272 [M+H]Cι 2 H 17 N0 4 S (271.3376) MS (ESI): 272 [M + H]
Beispiel 7Example 7
CnH13N04S (255.2946) MS (ESI) : 256 [M+H]CnH 13 N0 4 S (255.2946) MS (ESI): 256 [M + H]
Beispiel 8Example 8
C14H19N04S (297.3758) MS (ESI) : 298 [M+H] Beispiel 9C 14 H 19 N0 4 S (297.3758) MS (ESI): 298 [M + H] Example 9
C12Hι4F3N04S (325.3089) MS (ESI) : 326 [M+H]C 12 Hι 4 F 3 N0 4 S (325.3089) MS (ESI): 326 [M + H]
Beispiel 10Example 10
C15H15N05S (321.3545) MS (ESI) : 322 [M+H]C 15 H 15 N0 5 S (321.3545) MS (ESI): 322 [M + H]
Beispiel 11:Example 11:
C14H12BrN04S (370.2240) MS (ESI) : 371 [M+H] C 14 H 12 BrN0 4 S (370.2240) MS (ESI): 371 [M + H]
Beispiel 12:Example 12:
C16Hι7N04S (319.3822) MS (ESI) : 320 [M+H]C 16 Hι 7 N0 4 S (319.3822) MS (ESI): 320 [M + H]
Beispiel 13Example 13
CnH15N04S2 (289.3745) MS (ESI) : 290 [M+H]CnH 15 N0 4 S 2 (289.3745) MS (ESI): 290 [M + H]
Beispiel 14:Example 14:
C18H28N206S (400.4977) MS (ESI) : 401 [M+H]C 18 H 28 N 2 0 6 S (400.4977) MS (ESI): 401 [M + H]
Beispiel 15Example 15
Cι9H30N2O6S (414.5248) MS (ESI) : 415 [M+H]Cι 9 H 30 N 2 O 6 S (414.5248) MS (ESI): 415 [M + H]
Beispiel 16:Example 16:
C24H32N206S (476.5964) MS (ESI) : 477 [M+H]C 24 H 32 N 2 0 6 S (476.5964) MS (ESI): 477 [M + H]
Beispiel 17 Example 17
C28H47N308S (585.7661) MS (ESI) : 586 [M+H]C 28 H 47 N 3 0 8 S (585.7661) MS (ESI): 586 [M + H]
Beispiel 18:Example 18:
Die Verbindung aus Beispiel 15 (0.1 mmol) wird in 2 ml Dichlormethan (DCM) und 0.1 ml Trifluoressigsäure (TFA) gelöst und 1 h bei Raumtemperatur gerührt. Anschliessend wird das DCM/TFA-Gemisch im Vakuum entfernt und der Rückstand mittels HPLC gereinigt .The compound from Example 15 (0.1 mmol) is dissolved in 2 ml dichloromethane (DCM) and 0.1 ml trifluoroacetic acid (TFA) and stirred for 1 h at room temperature. The DCM / TFA mixture is then removed in vacuo and the residue is purified by HPLC.
Cι4H22N204S (314.4064) MS (ESI) : 315 [M+H]Cι 4 H 22 N 2 0 4 S (314.4064) MS (ESI): 315 [M + H]
Beispiel 19:Example 19:
Die Verbindung aus Beispiel 16 (0.1 mmol) wird in 2 ml Dichlormethan (DCM) und 0.1 ml Trifluoressigsäure (TFA) gelöst und 1 h bei Raumtemperatur gerührt. Anschliessend wird das DCM/TFA-Gemisch im Vakuum entfernt und der Rückstand mittels HPLC gereinigt .The compound from Example 16 (0.1 mmol) is dissolved in 2 ml of dichloromethane (DCM) and 0.1 ml of trifluoroacetic acid (TFA) and stirred at room temperature for 1 h. Subsequently the DCM / TFA mixture is removed in vacuo and the residue is purified by HPLC.
Cι9H24N204S ( 376 . 4781 ) MS (ESI ) : 377 [M+H]Cι 9 H 24 N 2 0 4 S (376. 4781) MS (ESI): 377 [M + H]
Beispiel 20 :Example 20:
Die Verbindung aus Beispiel 17 (0.1 mmol) wird in 2 ml Dichlormethan (DCM) und 0.1 ml Trifluoressigsäure (TFA) gelöst und 1 h bei Raumtemperatur gerührt. Anschliessend wird das DCM/TFA-Gemisch im Vakuum entfernt und der Rückstand mittels HPLC gereinigt.The compound from Example 17 (0.1 mmol) is dissolved in 2 ml of dichloromethane (DCM) and 0.1 ml of trifluoroacetic acid (TFA) and stirred at room temperature for 1 h. The DCM / TFA mixture is then removed in vacuo and the residue is purified by HPLC.
C18H31 3O4S (385.5295) MS (ESI) : 386 [M+H]C 18 H 3 1 3 O 4 S (385.5295) MS (ESI): 386 [M + H]
Beispiel 21 Example 21
Cι6Hι7N04S (319,38) MS (ESI) : 342 [M+Na]Cι 6 Hι 7 N0 4 S (319.38) MS (ESI): 342 [M + Na]
Beispiel 22Example 22
CnH15N04S (257,31) MS (ESI) : 280 [M+Na]CnH 15 N0 4 S (257.31) MS (ESI): 280 [M + Na]
Beispiel 23Example 23
C12H17N04S (271,33) MS (ESI) : 272 [M+H] , 294 [M+Na]C 12 H 17 N0 4 S (271.33) MS (ESI): 272 [M + H], 294 [M + Na]
Beispiel 24 Example 24
C18H28N206S (400,50) MS (ESI) : 401 [M+H] , 423 [M+Na] C 18 H 28 N 2 0 6 S (400.50) MS (ESI): 401 [M + H], 423 [M + Na]
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003250014A AU2003250014A1 (en) | 2002-07-09 | 2003-07-09 | Method for producing substituted thiazol-2-yl methyl esters |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2002130872 DE10230872A1 (en) | 2002-07-09 | 2002-07-09 | Process for the preparation of substituted thiazol-2-ylmethyl esters |
| DE10230872.1 | 2002-07-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2004005269A1 true WO2004005269A1 (en) | 2004-01-15 |
Family
ID=29761787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2003/007414 Ceased WO2004005269A1 (en) | 2002-07-09 | 2003-07-09 | Method for producing substituted thiazol-2-yl methyl esters |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2003250014A1 (en) |
| DE (1) | DE10230872A1 (en) |
| WO (1) | WO2004005269A1 (en) |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2409983A1 (en) | 2010-07-19 | 2012-01-25 | Leibniz-Institut für Pflanzenbiochemie (IPB) | Tubulysin analogues |
| WO2012171020A1 (en) | 2011-06-10 | 2012-12-13 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
| CN103333133A (en) * | 2013-06-13 | 2013-10-02 | 西北师范大学 | Synthesis method of key intermediate TUV of Tubulysin compound |
| WO2014093394A1 (en) | 2012-12-10 | 2014-06-19 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
| WO2014093640A1 (en) | 2012-12-12 | 2014-06-19 | Mersana Therapeutics,Inc. | Hydroxy-polmer-drug-protein conjugates |
| WO2015127685A1 (en) | 2014-02-28 | 2015-09-03 | Hangzhou Dac Biotech Co., Ltd | Charged linkers and their uses for conjugation |
| WO2015151081A2 (en) | 2015-07-12 | 2015-10-08 | Suzhou M-Conj Biotech Co., Ltd | Bridge linkers for conjugation of a cell-binding molecule |
| EP3210627A1 (en) | 2012-07-12 | 2017-08-30 | Hangzhou Dac Biotech Co., Ltd | Conjugates of cell binding molecules with cytotoxic agents |
| US10131682B2 (en) | 2012-11-24 | 2018-11-20 | Hangzhou Dac Biotech Co., Ltd. | Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules |
| WO2019051322A1 (en) * | 2017-09-08 | 2019-03-14 | Seattle Genetics, Inc. | Process for the preparation of tubulysins and intermediates thereof |
| US10232051B2 (en) | 2015-07-15 | 2019-03-19 | Hangzhou Dac Biotech Co., Ltd. | Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule |
| CN109912683A (en) * | 2017-12-13 | 2019-06-21 | 杭州多禧生物科技有限公司 | Cytotoxin molecule, conjugate, preparation method and application thereof |
| WO2021000067A1 (en) | 2019-06-29 | 2021-01-07 | 杭州多禧生物科技有限公司 | Cell-binding molecule-tubulysin derivative conjugate and preparation method therefor |
| EP3888691A1 (en) | 2016-11-14 | 2021-10-06 | Hangzhou Dac Biotech Co., Ltd. | Conjugation linkers, cell binding molecule-drug conjugates containing the likers, methods of making and uses such conjugates with the linkers |
| US11229708B2 (en) | 2015-12-04 | 2022-01-25 | Seagen Inc. | Conjugates of quaternized tubulysin compounds |
| WO2023078273A1 (en) | 2021-11-03 | 2023-05-11 | Hangzhou Dac Biotech Co., Ltd. | Specific conjugation for an antibody-drug conjugate |
| US11793880B2 (en) | 2015-12-04 | 2023-10-24 | Seagen Inc. | Conjugates of quaternized tubulysin compounds |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003051795A2 (en) * | 2001-12-18 | 2003-06-26 | Morphochem Ag | Resin-bonded isonitriles |
-
2002
- 2002-07-09 DE DE2002130872 patent/DE10230872A1/en not_active Withdrawn
-
2003
- 2003-07-09 WO PCT/EP2003/007414 patent/WO2004005269A1/en not_active Ceased
- 2003-07-09 AU AU2003250014A patent/AU2003250014A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003051795A2 (en) * | 2001-12-18 | 2003-06-26 | Morphochem Ag | Resin-bonded isonitriles |
Non-Patent Citations (2)
| Title |
|---|
| HECK S ET AL: "A versatile muti-component one-pot thiazole synthesis", SYNLETT, no. 3, March 2000 (2000-03-01), pages 424 - 426, XP002256980 * |
| YAMADA M ET AL: "A Novel Synthesis of Methyl 5-Substituted Thiazole-4-carboxylates Using 3-Bromo-2-isocyanoacrylates (BICA)", TETRAHEDRON LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 36, no. 2, 9 January 1995 (1995-01-09), pages 257 - 260, XP004189760, ISSN: 0040-4039 * |
Cited By (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9371358B2 (en) | 2010-07-19 | 2016-06-21 | Leibniz-Institut fur Pflanzenbiochemie | Tubulysin analogues |
| WO2012010287A1 (en) | 2010-07-19 | 2012-01-26 | Leibniz-Institut Für Pflanzenbiochemie | Tubulysin analogues |
| EP2409983A1 (en) | 2010-07-19 | 2012-01-25 | Leibniz-Institut für Pflanzenbiochemie (IPB) | Tubulysin analogues |
| WO2012171020A1 (en) | 2011-06-10 | 2012-12-13 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
| EP3228325A1 (en) | 2011-06-10 | 2017-10-11 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
| EP3348280A1 (en) | 2012-07-12 | 2018-07-18 | Hangzhou Dac Biotech Co., Ltd | Conjugates of cell binding molecules with cytotoxic agents |
| EP3210627A1 (en) | 2012-07-12 | 2017-08-30 | Hangzhou Dac Biotech Co., Ltd | Conjugates of cell binding molecules with cytotoxic agents |
| US10131682B2 (en) | 2012-11-24 | 2018-11-20 | Hangzhou Dac Biotech Co., Ltd. | Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules |
| WO2014093394A1 (en) | 2012-12-10 | 2014-06-19 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
| WO2014093640A1 (en) | 2012-12-12 | 2014-06-19 | Mersana Therapeutics,Inc. | Hydroxy-polmer-drug-protein conjugates |
| CN103333133B (en) * | 2013-06-13 | 2016-06-08 | 西北师范大学 | The synthetic method of a kind of Tubulysin family compound key intermediate TUV |
| CN103333133A (en) * | 2013-06-13 | 2013-10-02 | 西北师范大学 | Synthesis method of key intermediate TUV of Tubulysin compound |
| WO2015127685A1 (en) | 2014-02-28 | 2015-09-03 | Hangzhou Dac Biotech Co., Ltd | Charged linkers and their uses for conjugation |
| US10464955B2 (en) | 2014-02-28 | 2019-11-05 | Hangzhou Dac Biotech Co., Ltd. | Charged linkers and their uses for conjugation |
| US10696699B2 (en) | 2014-02-28 | 2020-06-30 | Hangzhou Dac Biotech Co., Ltd. | Charged linkers and their uses for conjugation |
| US10696700B2 (en) | 2014-02-28 | 2020-06-30 | Hangzhou Dac Biotech Co., Ltd. | Charged linkers and their uses for conjugation |
| US10683314B2 (en) | 2014-02-28 | 2020-06-16 | Hangzhou Dac Biotech Co., Ltd. | Charged linkers and their uses for conjugation |
| WO2015151081A2 (en) | 2015-07-12 | 2015-10-08 | Suzhou M-Conj Biotech Co., Ltd | Bridge linkers for conjugation of a cell-binding molecule |
| EP4678240A2 (en) | 2015-07-12 | 2026-01-14 | Hangzhou Dac Biotech Co., Ltd. | Bridge linkers for conjugation of cell-binding molecules |
| US10293055B2 (en) | 2015-07-15 | 2019-05-21 | Hangzhou Dac Biotech Co., Ltd. | Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule |
| US10232051B2 (en) | 2015-07-15 | 2019-03-19 | Hangzhou Dac Biotech Co., Ltd. | Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule |
| US10328157B2 (en) | 2015-07-15 | 2019-06-25 | Hangzhou Dac Biotech Co., Ltd. | Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule |
| US11793880B2 (en) | 2015-12-04 | 2023-10-24 | Seagen Inc. | Conjugates of quaternized tubulysin compounds |
| US11229708B2 (en) | 2015-12-04 | 2022-01-25 | Seagen Inc. | Conjugates of quaternized tubulysin compounds |
| EP3888691A1 (en) | 2016-11-14 | 2021-10-06 | Hangzhou Dac Biotech Co., Ltd. | Conjugation linkers, cell binding molecule-drug conjugates containing the likers, methods of making and uses such conjugates with the linkers |
| CN111601803A (en) * | 2017-09-08 | 2020-08-28 | 西雅图基因公司 | The preparation method of tubulin and its intermediate |
| US11389543B2 (en) | 2017-09-08 | 2022-07-19 | Seagen Inc. | Process for the preparation of tubulysins and intermediates thereof |
| AU2018329951B2 (en) * | 2017-09-08 | 2023-12-14 | Seagen Inc. | Process for the preparation of tubulysins and intermediates thereof |
| IL272837B1 (en) * | 2017-09-08 | 2024-02-01 | Seagen Inc | Process for the preparation of tubulysins and intermediates thereof |
| IL272837B2 (en) * | 2017-09-08 | 2024-06-01 | Seagen Inc | A process for preparing tubolysins and their intermediates |
| WO2019051322A1 (en) * | 2017-09-08 | 2019-03-14 | Seattle Genetics, Inc. | Process for the preparation of tubulysins and intermediates thereof |
| CN109912683B (en) * | 2017-12-13 | 2023-01-06 | 杭州多禧生物科技有限公司 | Cytotoxin molecule, conjugate, preparation method and application thereof |
| CN109912683A (en) * | 2017-12-13 | 2019-06-21 | 杭州多禧生物科技有限公司 | Cytotoxin molecule, conjugate, preparation method and application thereof |
| WO2021000067A1 (en) | 2019-06-29 | 2021-01-07 | 杭州多禧生物科技有限公司 | Cell-binding molecule-tubulysin derivative conjugate and preparation method therefor |
| WO2023078273A1 (en) | 2021-11-03 | 2023-05-11 | Hangzhou Dac Biotech Co., Ltd. | Specific conjugation for an antibody-drug conjugate |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003250014A1 (en) | 2004-01-23 |
| DE10230872A1 (en) | 2004-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1521769B1 (en) | Tubulysin conjugates | |
| WO2004005269A1 (en) | Method for producing substituted thiazol-2-yl methyl esters | |
| EP1523493B1 (en) | Novel tubulysin analogues | |
| DE69230824T2 (en) | NEW TETRAPEPTIDE DERIVATIVES | |
| EP2298762A2 (en) | Heterobicyclic compounds with antibacterial activity | |
| EP1626969A1 (en) | Heterocyclic compounds | |
| DE102005017116A1 (en) | Inhibitors of Inhibitors of Apoptosis Proteins (IAP) | |
| EP0538192B1 (en) | New 17-beta-substituted aza-androstanderivatives | |
| DE102005019181A1 (en) | New indene compound are peptide-deformylase inhibitors useful e.g. to treat or prevent diseases mediated by metalloproteinase activity and peptide-deformylase activity | |
| EP2374806A1 (en) | OXAZOLIDINON-QUINOLONe HYBRIDes and intermediates for their preparation | |
| DE69319902T2 (en) | NEW PERHYDROISOINDOL DERIVATIVES AND THEIR PRODUCTION | |
| DE69527786T2 (en) | DIAMINOMETHYLIDEN DERIVATIVES | |
| DE10320453A1 (en) | New Actinonin Bioisosteres | |
| EP2493851B1 (en) | Closthioamides | |
| EP1648447A1 (en) | Pyrazolines as par-1 antagonists for treatment of cardiovascular diseases | |
| WO2004007483A1 (en) | Novel macrocycles for the treatment of cancer diseases | |
| US11365201B2 (en) | Chlorotonil derivatives | |
| DE3445356A1 (en) | Halogenated thiophene compounds | |
| DE10150077B4 (en) | Process for the preparation of polymer-bound isonitriles | |
| DE102006062278A1 (en) | Preparing an amino acid derivative, comprises reacting carbonyl compound and amine compound, reacting obtained nitrogen containing carbonyl compound with aziridine compound and converting obtained compound to a carbonyl derivative | |
| CH651825A5 (en) | PROLIN DERIVATIVES AND METHOD FOR THEIR PRODUCTION. | |
| EP3666769A1 (en) | Novel caspase inhibitors | |
| DE2512084A1 (en) | NEW 8- (BETA-AMINOAETHYL) ERGOLIN-I- DERIVATIVES, THEIR SALTS AND THE PRODUCTION PROCESSES FOR THEM | |
| WO2006131340A2 (en) | Pyrrolones that act as peptide deformylase (pdf) inhibitors | |
| DE10327472A1 (en) | New thia-epothilone derivatives useful in the preparation of medicaments for the treatment of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |